chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Tenderness
Clinical narrative: Injection siite tenderness; This spontaneous case was reported by a consumer and describes the occurrence of TENDERNESS (Injection siite tenderness) in a 76-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 02-Mar-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced TENDERNESS (Injection siite tenderness). On 04-Mar-2021, TENDERNESS (Injection siite tenderness) had resolved.            No treatment information was reported. no concomitant was provided   This case was linked to MOD21-045818.   Most recent FOLLOW-UP information incorporated above includes: On 21-Jul-2021: Contact address updated
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Chest discomfort, Flushing, Headache, Lethargy, Pyrexia
Clinical narrative: Tightness in chest; Flushed; Grogginess; Sleepiness; Headache; Injection site soreness; Temperature; This spontaneous case was reported by a consumer and describes the occurrence of CHEST DISCOMFORT (Tightness in chest), FLUSHING (Flushed), LETHARGY (Grogginess), SOMNOLENCE (Sleepiness) and HEADACHE (Headache) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included CARVEDILOL, LEVOTHYROXINE SODIUM (SYNTHROID), FLUTICASONE PROPIONATE, SALMETEROL XINAFOATE (ADVAIR), LANSOPRAZOLE (PREVACID), HYDRALAZINE, ENALAPRIL and CLONIDINE for an unknown indication.    On 03-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Mar-2012, the patient experienced PYREXIA (Temperature). On 03-Mar-2021, the patient experienced CHEST DISCOMFORT (Tightness in chest), FLUSHING (Flushed), LETHARGY (Grogginess), SOMNOLENCE (Sleepiness), HEADACHE (Headache) and VACCINATION SITE PAIN (Injection site soreness). On 05-Mar-2021, CHEST DISCOMFORT (Tightness in chest), FLUSHING (Flushed), LETHARGY (Grogginess), SOMNOLENCE (Sleepiness) and PYREXIA (Temperature) had resolved. At the time of the report, HEADACHE (Headache) was resolving and VACCINATION SITE PAIN (Injection site soreness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   This case was linked to MOD-2021-043439.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Somnolence, Vaccination site pain
Clinical narrative: Tightness in chest; Flushed; Grogginess; Sleepiness; Headache; Injection site soreness; Temperature; This spontaneous case was reported by a consumer and describes the occurrence of CHEST DISCOMFORT (Tightness in chest), FLUSHING (Flushed), LETHARGY (Grogginess), SOMNOLENCE (Sleepiness) and HEADACHE (Headache) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included CARVEDILOL, LEVOTHYROXINE SODIUM (SYNTHROID), FLUTICASONE PROPIONATE, SALMETEROL XINAFOATE (ADVAIR), LANSOPRAZOLE (PREVACID), HYDRALAZINE, ENALAPRIL and CLONIDINE for an unknown indication.    On 03-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Mar-2012, the patient experienced PYREXIA (Temperature). On 03-Mar-2021, the patient experienced CHEST DISCOMFORT (Tightness in chest), FLUSHING (Flushed), LETHARGY (Grogginess), SOMNOLENCE (Sleepiness), HEADACHE (Headache) and VACCINATION SITE PAIN (Injection site soreness). On 05-Mar-2021, CHEST DISCOMFORT (Tightness in chest), FLUSHING (Flushed), LETHARGY (Grogginess), SOMNOLENCE (Sleepiness) and PYREXIA (Temperature) had resolved. At the time of the report, HEADACHE (Headache) was resolving and VACCINATION SITE PAIN (Injection site soreness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   This case was linked to MOD-2021-043439.
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Influenza like illness, Myalgia, Nausea
Clinical narrative: fells like the flu; arm was sore; Body aches/aching all over; low grade fever/her temperatures were normal but sometimes 99.5; Sick to stomach, no vomiting; Cold Chills; Mild Headache; This spontaneous case was reported by a consumer and describes the occurrence of   in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form.            Treatment medication was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 02-May-2021: follow up received as Consumer stated that she is doing Fine and no further follow up required.
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Pyrexia
Clinical narrative: fells like the flu; arm was sore; Body aches/aching all over; low grade fever/her temperatures were normal but sometimes 99.5; Sick to stomach, no vomiting; Cold Chills; Mild Headache; This spontaneous case was reported by a consumer and describes the occurrence of   in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form.            Treatment medication was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 02-May-2021: follow up received as Consumer stated that she is doing Fine and no further follow up required.
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Fatigue, Sinusitis
Clinical narrative: sinus infection; severe pain in the left shoulder; joint pain in both shoulders; joint pain in hips; fatigue; This spontaneous case was reported by a consumer and describes the occurrence of ARTHRALGIA (severe pain in the left shoulder), ARTHRALGIA (joint pain in both shoulders), ARTHRALGIA (joint pain in hips), FATIGUE (fatigue) and SINUSITIS (sinus infection) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 030L20A and 023M20A) for COVID-19 vaccination.     The patient's past medical history included Diabetic since an unknown date, Hypertension since an unknown date, Acid reflux (esophageal) (esophagus reflux) and Cancer in 2017. Concomitant products included CIPROFLOXACIN and DOXYCYCLINE for an unknown indication.   On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1. On 25-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 2. On 28-Jan-2021, the patient experienced ARTHRALGIA (severe pain in the left shoulder), ARTHRALGIA (joint pain in both shoulders), ARTHRALGIA (joint pain in hips) and FATIGUE (fatigue). On an unknown date, the patient experienced SINUSITIS (sinus infection). At the time of the report, ARTHRALGIA (severe pain in the left shoulder), ARTHRALGIA (joint pain in both shoulders), ARTHRALGIA (joint pain in hips), FATIGUE (fatigue) and SINUSITIS (sinus infection) had resolved.            The consumer stated that she has a cleft pallet and frequently gets sinus and ear infections. On 25Feb2021 she stated that she received the second dose in the series from the Moderna vaccine. The IM injection was given into the left arm. Lot # 023M20A reported. After the injection she reported experiencing muscle spams under the right eye that lasted for 2.5 days and resolved. On 05Mar2021, she reported muscle spasms in the upper right cheek and her left eye is hurting inside the eye and is swollen. She stated she is going to make an appointment with her HCP.
Age: 38.0
Sex: M
Vaccine: COVID19
Symptoms: Illness
Clinical narrative: Sicker than a dog; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (Sicker than a dog) in a 38-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    In January 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In January 2021, the patient experienced ILLNESS (Sicker than a dog). At the time of the report, ILLNESS (Sicker than a dog) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported. Patient may have took NSAID of some kind as treatment. Patient Ethnicity: Caucasian
Sex: M
Vaccine: COVID19
Symptoms: Abdominal discomfort, Chills, Dyspnoea, Nausea, Oropharyngeal pain
Clinical narrative: Lost his bowels; Heavy breathing; Sore Throat; The chills; Fever; Nauseated; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL DISCOMFORT (Lost his bowels), DYSPNOEA (Heavy breathing), OROPHARYNGEAL PAIN (Sore Throat), CHILLS (The chills) and PYREXIA (Fever) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Down's syndrome. Concomitant products included AMBRISENTAN (LETAIRIS), TADALAFIL (ADCIRCA), ALLOPURINOL, LEVOTHYROXINE, OMEPRAZOLE and SPIRONOLACTONE for an unknown indication.    On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Mar-2021, the patient experienced ABDOMINAL DISCOMFORT (Lost his bowels), DYSPNOEA (Heavy breathing), OROPHARYNGEAL PAIN (Sore Throat), CHILLS (The chills), PYREXIA (Fever) and NAUSEA (Nauseated). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 1 dosage form. At the time of the report, ABDOMINAL DISCOMFORT (Lost his bowels), DYSPNOEA (Heavy breathing), OROPHARYNGEAL PAIN (Sore Throat), CHILLS (The chills), PYREXIA (Fever) and NAUSEA (Nauseated) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Other relevant medication history included vitamin D.
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Lost his bowels; Heavy breathing; Sore Throat; The chills; Fever; Nauseated; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL DISCOMFORT (Lost his bowels), DYSPNOEA (Heavy breathing), OROPHARYNGEAL PAIN (Sore Throat), CHILLS (The chills) and PYREXIA (Fever) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Down's syndrome. Concomitant products included AMBRISENTAN (LETAIRIS), TADALAFIL (ADCIRCA), ALLOPURINOL, LEVOTHYROXINE, OMEPRAZOLE and SPIRONOLACTONE for an unknown indication.    On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Mar-2021, the patient experienced ABDOMINAL DISCOMFORT (Lost his bowels), DYSPNOEA (Heavy breathing), OROPHARYNGEAL PAIN (Sore Throat), CHILLS (The chills), PYREXIA (Fever) and NAUSEA (Nauseated). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 1 dosage form. At the time of the report, ABDOMINAL DISCOMFORT (Lost his bowels), DYSPNOEA (Heavy breathing), OROPHARYNGEAL PAIN (Sore Throat), CHILLS (The chills), PYREXIA (Fever) and NAUSEA (Nauseated) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Other relevant medication history included vitamin D.
Sex: F
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: Headache; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Headache) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HEADACHE (Headache). At the time of the report, HEADACHE (Headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product information, if any, was not provided by the reporter. Treatment information, if any, was not provided
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Sinusitis
Clinical narrative: Sinus infection; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of SINUSITIS (Sinus infection) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 024M20A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included CLARITHROMYCIN (CLARITIN [CLARITHROMYCIN]) for an unknown indication.    On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced SINUSITIS (Sinus infection). At the time of the report, SINUSITIS (Sinus infection) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.        No treatment information was provided.
Age: 84.0
Sex: F
Vaccine: COVID19
Symptoms: Chest pain, Chills, Vaccination site pain
Clinical narrative: chest pains; pain at the injection site, left arm; horrible chills; This spontaneous case was reported by a consumer and describes the occurrence of CHEST PAIN (chest pains), VACCINATION SITE PAIN (pain at the injection site, left arm) and CHILLS (horrible chills) in an 84-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination.     Concurrent medical conditions included Breast cancer (for which she had chemotherapy and radiation.), Knee injury (she gets regular injections.) and Heart disorder (hole in heart). Concomitant products included TAMOXIFEN for Breast cancer.   On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 04-Mar-2021, the patient experienced CHEST PAIN (chest pains), VACCINATION SITE PAIN (pain at the injection site, left arm) and CHILLS (horrible chills). The patient was treated with PARACETAMOL (TYLENOL EXTRA STRENGTH) at an unspecified dose and frequency. At the time of the report, CHEST PAIN (chest pains), VACCINATION SITE PAIN (pain at the injection site, left arm) and CHILLS (horrible chills) outcome was unknown.
Sex: M
Vaccine: COVID19, UNK
Symptoms: COVID-19, SARS-CoV-2 test
Clinical narrative: Tested positive for COVID-19; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Tested positive for COVID-19) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product BAMLANIVIMAB for an unknown indication.    No medical history was provided by the reporter.    On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient started BAMLANIVIMAB (unknown route) 1 dosage form. On 16-Feb-2021, the patient experienced COVID-19 (Tested positive for COVID-19). At the time of the report, COVID-19 (Tested positive for COVID-19) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 16-Feb-2021, SARS-CoV-2 test: positive (Positive) Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient has been administered with a monoclonal antibody. No relevant concomitant medications reported.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Feb-2021, the patient experienced PAIN IN EXTREMITY (Sore arm). At the time of the report, PAIN IN EXTREMITY (Sore arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications reported.  No treatment information was provided.    This case was linked to MOD-2021-036535 (Patient Link).
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Lymphadenitis, Lymphadenopathy
Clinical narrative: lymphadenitis; puffy, large, red, swollen ymph node under his left armpit; This spontaneous case was reported by a consumer and describes the occurrence of LYMPHADENITIS (lymphadenitis) and LYMPHADENOPATHY (puffy, large, red, swollen ymph node under his left armpit) in a 69-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 milliliter. On 04-Mar-2021, the patient experienced LYMPHADENITIS (lymphadenitis) and LYMPHADENOPATHY (puffy, large, red, swollen ymph node under his left armpit). At the time of the report, LYMPHADENITIS (lymphadenitis) and LYMPHADENOPATHY (puffy, large, red, swollen ymph node under his left armpit) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported. No treatment medications were provided by the reporter.   Most recent FOLLOW-UP information incorporated above includes: On 05-Aug-2021: Significant TCR follow up received included information about the outcome of the events and was updated. Reported verbatim for the event Swollen lymph nodes was updated as per the previous report.
Age: 74.0
Sex: U
Vaccine: COVID19
Symptoms: Joint stiffness, Vaccination site pain
Clinical narrative: Joint Stiffness; pain at injection site (right); This spontaneous case was reported by a consumer and describes the occurrence of JOINT STIFFNESS (Joint Stiffness) and VACCINATION SITE PAIN (pain at injection site (right)) in a 74-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013A21A) for COVID-19 vaccination.     Concomitant products included TOCILIZUMAB (ACTEMRA) for an unknown indication.    On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Mar-2021, the patient experienced JOINT STIFFNESS (Joint Stiffness) and VACCINATION SITE PAIN (pain at injection site (right)). At the time of the report, JOINT STIFFNESS (Joint Stiffness) and VACCINATION SITE PAIN (pain at injection site (right)) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Reporter did not allow further contact
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Accidental overdose, Inappropriate schedule of product administration, Vaccination site pain
Clinical narrative: Received 1st and 2nd dose on the same day, 15 minutes apart; Received 1st and 2nd dose on the same day, 15 minutes apart; Left arm pain/ right arm pain; This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Received 1st and 2nd dose on the same day, 15 minutes apart), ACCIDENTAL OVERDOSE (Received 1st and 2nd dose on the same day, 15 minutes apart) and VACCINATION SITE PAIN (Left arm pain/ right arm pain) in a 71-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 002A21A and 002A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 03-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Mar-2021, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 03-Mar-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Received 1st and 2nd dose on the same day, 15 minutes apart), ACCIDENTAL OVERDOSE (Received 1st and 2nd dose on the same day, 15 minutes apart) and VACCINATION SITE PAIN (Left arm pain/ right arm pain). On 03-Mar-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Received 1st and 2nd dose on the same day, 15 minutes apart) and ACCIDENTAL OVERDOSE (Received 1st and 2nd dose on the same day, 15 minutes apart) had resolved. At the time of the report, VACCINATION SITE PAIN (Left arm pain/ right arm pain) had not resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Based on the current available information and temporal association between the use of the product and the start date of the arm pain, a causal relationship cannot be excluded.  Patient was given two doses of the Moderna COVID19 vaccine on the same day in March hence nurse indicated not to take previously scheduled 01-APR-2021 dose 2 therefore patient did not receive second dose.  No relevant concomitant medicine were provided.  Treatment information was not provided.   This case was linked to MOD-2021-036385, MOD21-086394 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 04-May-2021: Non significant follow up received, Email id updated for reporter information. On 26-Jul-2021: Follow up received included no newinformation. On 06-Aug-2021: Follow-up received: Information about dose 2 intake updated.
Sex: M
Vaccine: COVID19
Symptoms: Somnolence
Clinical narrative: SLEEPY; A spontaneous report was received from a consumer concerning her friend, a female patient in her 80's who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events sleepiness.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On unknown date, prior to the onset of the events the patient received their first of two planned doses of mRNA-1273 (lot/batch: unknown) through unknown route in the unknown location for prophylaxis of COVID-19 infection. On unknown date, prior to the onset of the events the patient received their second of two planned doses of mRNA-1273 (lot/batch: unknown) through unknown route in the unknown location for prophylaxis of COVID-19 infection.  On an unknown date, after receiving second dose of vaccination patient experienced sleepiness.  No treatment information was provided.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of event sleepiness was unknown.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Contusion, Magnetic resonance imaging, Pain in extremity, Peripheral swelling
Clinical narrative: finger started swelling; Potential Small Finger Vasculitis; Intense Finger Pain; Bruising on the Finger; wrist on that same hand started hurting; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PAIN IN EXTREMITY (Intense Finger Pain), CONTUSION (Bruising on the Finger), ARTHRALGIA (wrist on that same hand started hurting), PERIPHERAL SWELLING (finger started swelling) and VASCULITIS (Potential Small Finger Vasculitis) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025J20A) for COVID-19 vaccination.     No Medical History information was reported.    On 28-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Jan-2021, the patient experienced PAIN IN EXTREMITY (Intense Finger Pain), CONTUSION (Bruising on the Finger) and ARTHRALGIA (wrist on that same hand started hurting). On 20-Jan-2021, the patient experienced PERIPHERAL SWELLING (finger started swelling) and VASCULITIS (Potential Small Finger Vasculitis). At the time of the report, PAIN IN EXTREMITY (Intense Finger Pain), CONTUSION (Bruising on the Finger), ARTHRALGIA (wrist on that same hand started hurting), PERIPHERAL SWELLING (finger started swelling) and VASCULITIS (Potential Small Finger Vasculitis) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In January 2021, Magnetic resonance imaging: potential small vasculitis (abnormal) Potential small vasculitis..     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications or treatment details reported.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Vasculitis
Clinical narrative: finger started swelling; Potential Small Finger Vasculitis; Intense Finger Pain; Bruising on the Finger; wrist on that same hand started hurting; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PAIN IN EXTREMITY (Intense Finger Pain), CONTUSION (Bruising on the Finger), ARTHRALGIA (wrist on that same hand started hurting), PERIPHERAL SWELLING (finger started swelling) and VASCULITIS (Potential Small Finger Vasculitis) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025J20A) for COVID-19 vaccination.     No Medical History information was reported.    On 28-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Jan-2021, the patient experienced PAIN IN EXTREMITY (Intense Finger Pain), CONTUSION (Bruising on the Finger) and ARTHRALGIA (wrist on that same hand started hurting). On 20-Jan-2021, the patient experienced PERIPHERAL SWELLING (finger started swelling) and VASCULITIS (Potential Small Finger Vasculitis). At the time of the report, PAIN IN EXTREMITY (Intense Finger Pain), CONTUSION (Bruising on the Finger), ARTHRALGIA (wrist on that same hand started hurting), PERIPHERAL SWELLING (finger started swelling) and VASCULITIS (Potential Small Finger Vasculitis) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In January 2021, Magnetic resonance imaging: potential small vasculitis (abnormal) Potential small vasculitis..     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications or treatment details reported.
Sex: M
Vaccine: COVID19
Symptoms: Anxiety, Neuralgia, Pain in extremity
Clinical narrative: concerned administer hit a nerve.; concerned administer hit a nerve.; extremely sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (extremely sore arm), NEURALGIA (concerned administer hit a nerve.) and ANXIETY (concerned administer hit a nerve.) in a 69-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 03-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Mar-2021, the patient experienced PAIN IN EXTREMITY (extremely sore arm). On an unknown date, the patient experienced NEURALGIA (concerned administer hit a nerve.) and ANXIETY (concerned administer hit a nerve.). At the time of the report, PAIN IN EXTREMITY (extremely sore arm), NEURALGIA (concerned administer hit a nerve.) and ANXIETY (concerned administer hit a nerve.) outcome was unknown.            no concomitant medications are provided.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: Rash all over arms, legs, and feet; This spontaneous case was reported by a consumer and describes the occurrence of RASH (Rash all over arms, legs, and feet) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 004M20A) for COVID-19 vaccination.     Concomitant products included CARVEDILOL, NICARDIPINE, ATORVASTATIN, LATANOPROST and ACETYLSALICYLIC ACID (ASPIRIN (E.C.)) for an unknown indication.    On 17-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Feb-2021, the patient experienced RASH (Rash all over arms, legs, and feet). At the time of the report, RASH (Rash all over arms, legs, and feet) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment includes steroids cream (Triamcinolone acetonide cream usp.1%).
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Paraesthesia oral, Swollen tongue
Clinical narrative: mild tongue swelling; tingling lips; This spontaneous case was reported by a nurse and describes the occurrence of SWOLLEN TONGUE (mild tongue swelling) and PARAESTHESIA ORAL (tingling lips) in a 35-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011J20A) for COVID-19 vaccination.     No Medical History information was reported.    On 30-Mar-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Mar-2021, the patient experienced SWOLLEN TONGUE (mild tongue swelling) and PARAESTHESIA ORAL (tingling lips). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) (oral) for Adverse event, at a dose of 25 milligram once. At the time of the report, SWOLLEN TONGUE (mild tongue swelling) and PARAESTHESIA ORAL (tingling lips) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications provided.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Injection site warmth, Myalgia, Pain in extremity
Clinical narrative: arm pain; injection site warmth; body aches; chills; headache; This spontaneous pregnancy case was reported by an other health care professional and describes the occurrence of PAIN IN EXTREMITY (arm pain), INJECTION SITE WARMTH (injection site warmth), MYALGIA (body aches), CHILLS (chills) and HEADACHE (headache) in a 34-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.   On 27-Jan-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 2 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. Last menstrual period and estimated date of delivery were not provided. On 28-Jan-2021, the patient experienced PAIN IN EXTREMITY (arm pain), INJECTION SITE WARMTH (injection site warmth), MYALGIA (body aches), CHILLS (chills) and HEADACHE (headache). At the time of the report, PAIN IN EXTREMITY (arm pain), INJECTION SITE WARMTH (injection site warmth), MYALGIA (body aches), CHILLS (chills) and HEADACHE (headache) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medications was not provided. Treatment information was not provided.
Age: 20.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Fatigue, Headache, Injection site induration
Clinical narrative: noted mild swelling and a small knot was felt in his left arm at the injection site; left arm pain; fatigue; headache; muscle pain; nausea; chills; noted mild swelling and a small knot was felt in his left arm at the injection site; joint pain; This spontaneous case was reported by a nurse and describes the occurrence of VACCINATION SITE SWELLING (noted mild swelling and a small knot was felt in his left arm at the injection site), PAIN IN EXTREMITY (left arm pain), FATIGUE (fatigue), HEADACHE (headache) and MYALGIA (muscle pain) in a 20-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011J20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Drug allergy (Albuterol allergy), Latex allergy, Drug allergy (Tylenol allergy), Drug allergy (Amoxicillin allergy) and Drug allergy (Augmentin allergy).    On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Mar-2021, the patient experienced VACCINATION SITE SWELLING (noted mild swelling and a small knot was felt in his left arm at the injection site), PAIN IN EXTREMITY (left arm pain), FATIGUE (fatigue), HEADACHE (headache), MYALGIA (muscle pain), NAUSEA (nausea), CHILLS (chills), INJECTION SITE INDURATION (noted mild swelling and a small knot was felt in his left arm at the injection site) and ARTHRALGIA (joint pain). At the time of the report, VACCINATION SITE SWELLING (noted mild swelling and a small knot was felt in his left arm at the injection site), PAIN IN EXTREMITY (left arm pain), FATIGUE (fatigue), HEADACHE (headache), MYALGIA (muscle pain), NAUSEA (nausea), CHILLS (chills), INJECTION SITE INDURATION (noted mild swelling and a small knot was felt in his left arm at the injection site) and ARTHRALGIA (joint pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications or treatment details reported. It was explained to the patient that these are side effects of the vaccine and, if his condition worsened, he was to follow up with his medical provider and he was also to follow up with our onsite nurse.    Most recent FOLLOW-UP information incorporated above includes: On 03-May-2021: NNI On 04-May-2021: Additional info-2 : VAERS
Age: 20.0
Sex: M
Vaccine: COVID19
Symptoms: Myalgia, Nausea, Pain in extremity, Vaccination site swelling
Clinical narrative: noted mild swelling and a small knot was felt in his left arm at the injection site; left arm pain; fatigue; headache; muscle pain; nausea; chills; noted mild swelling and a small knot was felt in his left arm at the injection site; joint pain; This spontaneous case was reported by a nurse and describes the occurrence of VACCINATION SITE SWELLING (noted mild swelling and a small knot was felt in his left arm at the injection site), PAIN IN EXTREMITY (left arm pain), FATIGUE (fatigue), HEADACHE (headache) and MYALGIA (muscle pain) in a 20-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011J20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Drug allergy (Albuterol allergy), Latex allergy, Drug allergy (Tylenol allergy), Drug allergy (Amoxicillin allergy) and Drug allergy (Augmentin allergy).    On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Mar-2021, the patient experienced VACCINATION SITE SWELLING (noted mild swelling and a small knot was felt in his left arm at the injection site), PAIN IN EXTREMITY (left arm pain), FATIGUE (fatigue), HEADACHE (headache), MYALGIA (muscle pain), NAUSEA (nausea), CHILLS (chills), INJECTION SITE INDURATION (noted mild swelling and a small knot was felt in his left arm at the injection site) and ARTHRALGIA (joint pain). At the time of the report, VACCINATION SITE SWELLING (noted mild swelling and a small knot was felt in his left arm at the injection site), PAIN IN EXTREMITY (left arm pain), FATIGUE (fatigue), HEADACHE (headache), MYALGIA (muscle pain), NAUSEA (nausea), CHILLS (chills), INJECTION SITE INDURATION (noted mild swelling and a small knot was felt in his left arm at the injection site) and ARTHRALGIA (joint pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications or treatment details reported. It was explained to the patient that these are side effects of the vaccine and, if his condition worsened, he was to follow up with his medical provider and he was also to follow up with our onsite nurse.    Most recent FOLLOW-UP information incorporated above includes: On 03-May-2021: NNI On 04-May-2021: Additional info-2 : VAERS
Sex: F
Vaccine: COVID19
Symptoms: Maternal exposure during pregnancy
Clinical narrative: vaccinated while pregnant; This spontaneous prospective pregnancy case was reported by a nurse and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (vaccinated while pregnant) in a 30-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination.     Concomitant products included MINERALS NOS, VITAMINS NOS (PRENATAL VITAMINS [MINERALS NOS;VITAMINS NOS]) and VITAMIN D [VITAMIN D NOS] for an unknown indication.    On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient's last menstrual period was in May 2020 and the estimated date of delivery was 30-Mar-2021. On 12-Feb-2021, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (vaccinated while pregnant). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) during pregnancy.  On 12-Feb-2021, MATERNAL EXPOSURE DURING PREGNANCY (vaccinated while pregnant) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Patient reported no medical history No treatment was reported  The patient was 36 weeks pregnant.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Exposure during pregnancy, Pregnancy test, Ultrasound scan
Clinical narrative: Vaccine exposure during pregnancy; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy) in a 36-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011A21A) for COVID-19 vaccination.     Concurrent medical conditions included Autoimmune disorder NOS (autoimmune shostayed the samelgreens syndrome.). Concomitant products included MINERALS NOS, VITAMINS NOS (PRENATAL VITAMINS [MINERALS NOS;VITAMINS NOS]), PARACETAMOL (TYLENOL) and AMOXICILLIN for an unknown indication.    On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. The patient's last menstrual period was in October 2020 and the estimated date of delivery was 09-Jul-2021. On 05-Mar-2021, the patient experienced EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) during pregnancy. The delivery occurred on an unknown date, which was reported as Unknown. For neonate 1, The outcome was reported as Unknown. On 05-Mar-2021, EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 28-Oct-2020, Pregnancy test: positive (Positive) Positive. On an unknown date, Ultrasound scan: normal (normal) normal.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Reported that patient has taken Tylenol and amoxicillin during this pregnancy. No treatment details reported.   Most recent FOLLOW-UP information incorporated above includes: On 05-Mar-2021: Internal review on 29-JUL-2021 resulted in update of Case setting, lab data, Concomitant drugs and narrative regenerated
Sex: F
Vaccine: COVID19
Symptoms: Maternal exposure during pregnancy, Pregnancy test
Clinical narrative: pregnant and received first dose of vaccine; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (pregnant and received first dose of vaccine) in a 29-year-old female patient (gravida 3, para 1) who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Spontaneous abortion in 2016. Concurrent medical conditions included Gestational diabetes and Type 2 diabetes mellitus in 2016. Concomitant products included INSULIN for Diabetes mellitus, MINERALS NOS, VITAMINS NOS (PRENATAL VITAMINS [MINERALS NOS;VITAMINS NOS]) from 01-Jan-2021 to an unknown date for an unknown indication.    On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient's last menstrual period was on 01-Nov-2020 and the estimated date of delivery was 21-Aug-2021. On 03-Mar-2021, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (pregnant and received first dose of vaccine). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the  seventeenth week of the pregnancy.  On 03-Mar-2021, MATERNAL EXPOSURE DURING PREGNANCY (pregnant and received first dose of vaccine) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 03-Dec-2020, Pregnancy test: Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Estimated date of conception 01-Nov-2020. On 01-Jan-2021 ultrasound done results -not provided. Previous pregnancy end date included 01-Apr-2019 with live birth. No treatment information provided.
Sex: M
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: Had a significant rash; This spontaneous case was reported by a consumer and describes the occurrence of RASH (Had a significant rash) in a 65-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 0UM28) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Feb-2021, the patient experienced RASH (Had a significant rash). At the time of the report, RASH (Had a significant rash) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.    No treatment information was reported.   Reporter did not allow further contact
Sex: F
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: Rash on neck; Rash and throat; This spontaneous case was reported by a consumer and describes the occurrence of RASH (Rash on neck) and RASH (Rash and throat) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-Mar-2021, the patient experienced RASH (Rash on neck) and RASH (Rash and throat). At the time of the report, RASH (Rash on neck) and RASH (Rash and throat) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment details included Benadryl, Cortisone cream.  Upon internal review on 21-May-2021, the age was corrected to unknown.
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Arm was not so sore; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm was not so sore) in a 121-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Mar-2021, the patient experienced PAIN IN EXTREMITY (Arm was not so sore). At the time of the report, PAIN IN EXTREMITY (Arm was not so sore) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Upon internal review on 21-May-2021, the age was corrected to unknown. No concomitant medication details were provided. No treatment medication details were provided.   Reporter did not allow further contact
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Hurt arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Hurt arm) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Cancer (Cancer Remission .).    On 07-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Hurt arm). At the time of the report, PAIN IN EXTREMITY (Hurt arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant information was reported. Treatment information was not reported.   Reporter did not allow further contact
Sex: M
Vaccine: COVID19
Symptoms: Chest X-ray, Cough, Oxygen saturation
Clinical narrative: dry cough; This spontaneous case was reported by a consumer and describes the occurrence of COUGH (dry cough) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 015M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Feb-2021, the patient experienced COUGH (dry cough). The patient was treated with AZITHROMYCIN (Z-PAK) at an unspecified dose and frequency. At the time of the report, COUGH (dry cough) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 19-Feb-2021, Chest X-ray: normal (normal) Normal. On 19-Feb-2021, Oxygen saturation: normal (normal) normal. On 22-Feb-2021, Oxygen saturation: 89-92 (Low) decreased.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.   Most recent FOLLOW-UP information incorporated above includes: On 28-Apr-2021: F/U received on 28 APR 2021, reporter email ID updated.